WaveMan
WaveMan · Company
FMCB · Farmers & Merchants Bancorp
> Search tickers & screens ⌘K
LIVE
← All companies

FMCB Farmers & Merchants Bancorp (FMCB) Insider Trading, Ownership & Congress Trades

Banks · National commercial banks · CIK 0001085913
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter

Farmers & Merchants Bancorp insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for FARMERS & MERCHANTS BANCORP in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
SANGUINETTI KEVIN
Director
BUY
2025-11-06 SECtraded 2025-11-05
10
$10.4K
+45.0%
Context
  • 5 earlier Form 4 trades (code P or S) here by this insider (5 buys), the last on Jun 22, 2022.
  • +1.4% median (+1.4% mean) 90-day return after 2 previous buys.
  • The trade is 1.4% of the 727 shares held after it.
  • No other insider bought within 30 days.
Insider activity: Director SANGUINETTI KEVIN bought about $10.4K of FMCB on Nov 5, 2025, the largest insider purchase at the company since 2023.
SUESS CALVIN J
Director
SELL
2024-09-30 SECtraded 2024-07-22
300
$291.1K
+55.9%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Mar 23, 2022.
  • The trade is 16.7% of the 1,800 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Director SUESS CALVIN J sold about $291.1K of FMCB on Jul 22, 2024, the largest insider sale at the company on our record.
James Craig W.
Director
BUY
2023-08-10 SEC
50
$48.2K
+59.7%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Mar 23, 2022.
  • The trade is 60.2% of the 83 shares held after it.
  • No other insider bought within 30 days.
Insider activity: Director James Craig W. bought about $48.2K of FMCB on Aug 10, 2023, the largest insider purchase at the company since 2022.
SANGUINETTI KEVIN
Director
BUY
2022-06-23 SECtraded 2022-06-22
10
$9.2K
+71.5%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Mar 23, 2022.
  • The trade is 100.0% of the 10 shares held after it.
  • No other insider bought within 30 days.
Insider activity: Director SANGUINETTI KEVIN bought about $9.2K of FMCB on Jun 22, 2022.
SANGUINETTI KEVIN
Director
BUY
2022-06-23 SECtraded 2022-06-22
10
$9.2K
+71.5%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Mar 23, 2022.
  • The trade is 100.0% of the 10 shares held after it.
  • No other insider bought within 30 days.
Insider activity: Director SANGUINETTI KEVIN bought about $9.2K of FMCB on Jun 22, 2022.
25 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 20 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
$2.9M repurchased, FY to 2025-12-31
below 60% of Banks
Short interest
<0.1% of the float short (float per yahoo 2026-10-26) · 1.0 days to cover · settled 2026-09-30
the lowest in Banks
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch FMCB

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+47.9%12M
+0%+17%+35%+52%2025-102025-122026-022026-042026-062026-082026-10 2025-11-05 · SANGUINETTI KEVIN bought $10.4K
Insider buy
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns FMCB: institutional holders (13F)

13F holdings, latest reported quarter
SEC 13F
No reported 13F holders

No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.

Congress trades in FMCB

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

FMCB planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Executive pay vs shareholder return · Mr. Steinwert
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$12.6M
$13.3M
$2.7M
+60%
+47%
2024
$6.2M
$6.2M
$1.8M
+51%
+24%
2023
$6.1M
$6.1M
$1.7M
+65%
+30%
2022
$6.1M
$6.1M
$1.8M
+70%
+20%
2021
$5.1M
$5.1M
$1.6M
+53%
+27%
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
UMBFBWFGPBPEBOFMBMGABCNEWTPCBDCOMISBAWSBFJMSB

FMCB financials

Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Free cash flow, TTM
$99.6M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
n/a
no debt line filed
Cash flow to debt
n/a
no debt line filed
Return on equity
+14.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+1.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
P/E, trailing
10.43x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
Enterprise value
n/a
no debt line filed
FCF yield
+9.9%
TTM free cash flow over market value at close 2026-10-27
PEG, trailing
1.01x
P/E over trailing EPS growth of 10%: four quarters to 2026-06-30 against the four to 2025-06-30
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Net income$93.6M$88.5M$88.3M$75.1M
EPS (diluted)133.96121.02116.6196.55
Operating cash flow$104.2M$103.7M$93.3M$101.8M
Cash$144.9M$212.6M$410.6M$588.3M
Buybacks$2.9M$45.3M$20.4M$20.3M
Dividends paid$13.8M$13.0M$12.9M$12.5M
SEC XBRL, fiscal years, as known on 2026-10-28

FMCB Stock Sonar score 2/7 axes

Find similar shapesCompare
Profitability
89
Inputs
  • Return on equity+14.9% · 87 pct, sector of 327
  • Return on assets+1.7% · 90 pct, sector of 334
  • Return on invested capitalfewer than four consecutive quarters of operating income
  • Return on capital employedfewer than four consecutive quarters of operating income
Risk and compliance
100
Inputs
  • Short interest, % of float+0.0% · 100 pct, sector of 378
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
5 not measured: Financial health, Growth, Insider conviction, Institutional and government, US patents
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

2 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies